Technical Data
H7022-35A
Homeobox Protein DLX-5 (DLX5)
Description:
This protein belongs to the the distal-less homeobox family. It contains one homeobox DNA-binding domain. It is thought to play a role in bone development and fracture healing. It is first expressed at 8.5 to 9 days in facial and branchial arch mesenchyme, otic vesicles and frontonasal ectoderm around olfactory placodes. At day 9.5-10, expression is seen in the developing forebrain. In day 12.5 embryos it is expressed in the brain and bones and also in all skeletal structures of midgestattion embryos after the first catilage formation. Expression remains unaltered in both brain and skeleton in day 15 embryos and slowly decreases in day 17 embryos. The unprocessed precursor has a length of 289 amino acids and a predicted molecular weight of 31.5kD.

Applications:
Suitable for use in ELISA. Other applications not tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with sterile 40-50% glycerol, ddH2O. Reconstituted product is stable for 12 months at -20C. Aliquot and store at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
MabIgG9G371Affinity Purified
SizeStorageShippingSourceHost
100ug-20CBlue IceHumanMouse
Concentration:
As reported
Immunogen:
Partial recombinant protein of human homeobox protein DLX-5 (aa1-10) with a GST tag.
Purity:
Purified by affinity chromatography.
Form
Supplied as a lyophilized powder in PBS, pH 7.2. Reconstitute with 100ul sterile ddH2O.
Specificity:
Recognizes human DLX5.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.